More News For Amgen (AMGN):
Dendreon (DNDN) Gains 17.5% After FDA Criticizes Rival Drug
Monday, February 06, 2012... Dendreon (NASDAQ: DNDN) jumped Monday after the FDA published a critical review of rival Amgen's (AMGN) drug for prostate cancer. Dendreon's top......
http://www.marketintelligencecenter.com/newsbites/1332804
Amgen (AMGN) Trading Near $68.53 Support Level
Monday, February 06, 2012... Amgen (NASDAQ:AMGN) closed Friday's winning trading session at $69.28. In the past year, the stock has hit a 52-week low of $47.66 and 52-week high......
http://www.marketintelligencecenter.com/analyfav/1332587
Amgen (AMGN) Could Fall Through $66.82 Support Level
Tuesday, January 31, 2012... Amgen Inc (NASDAQ: AMGN) closed Monday's trading session at $68.33. In the past year, the stock has hit a 52-week low of $47.66 and 52-week high of......
http://www.marketintelligencecenter.com/analyfav/1331399
Amgen (AMGN) Could Break Through $69.40 Resistance Level
Wednesday, January 25, 2012... Amgen Inc (NASDAQ: AMGN) closed Tuesday's trading session at $68.19. In the past year, the stock has hit a 52-week low of $47.66 and 52-week high of......
http://www.marketintelligencecenter.com/analyfav/1330030